Sinclair Pharmaceuticals has acquired 3 companies of its own, including 1 in the last 5 years. A total of 2 acquisitions came from private equity firms.
Sinclair Pharmaceuticals’ largest acquisition to date was in 2006, when it acquired Ashbourne Pharmaceuticals for $2M. Sinclair Pharmaceuticals has acquired in 2 different US states, and 2 countries. The Company’s most targeted sectors include medical products (67%) and life science (34%).
Join Mergr and gain access to Sinclair Pharmaceuticals’ M&A summary, the M&A summaries of companies just like it, as well as recent M&A activity in the life science sector.
M&A Total Activity3
- M&A Buy Activity3
- Total Sectors Invested 2
- Total Countries Invested 2
- M&A Buy/Sell Connections 2